FDA issues warning on 4 widely-used asthma drugs

(AP) -- The government is issuing new restrictions on some widely used long-acting asthma drugs, saying they should never be used without other asthma controllers to prevent a lifethreatening risk.

Four medications - Foradil, Serevent, Advair and Symbicort - contain an ingredient that relaxes muscles in the lung's airways. While they're very helpful for some patients, the way they work also may mask symptoms that can trigger serious attacks. It's a particular concern for children.

The ordered new labels saying the drugs should be used for the shortest possible duration - and only together with other medications such as inhaled steroids that work differently, by relieving airway inflammation.


Explore further

Cells that mediate steroid-resistant asthma identified by scientists at Children's Hospital

©2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: FDA issues warning on 4 widely-used asthma drugs (2010, February 18) retrieved 28 January 2020 from https://medicalxpress.com/news/2010-02-fda-issues-widely-used-asthma-drugs.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments